Delivery Order SPE2DB24D1034-SPE2DB24FWBE9

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,210.86, is for the procurement of 4566845391 - NALOXONE 0.4 MG/ML VIALML. The contract has a completion date of January 7, 2025 and is a Firm Fixed Price contract. This order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA...
This federal contract award, valued at $3,903.43, was issued by the Medical Supply Chain agency of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.4 mg/ml naloxone vials, a critical medication used to treat opioid overdoses. The contract is a firm fixed-price delivery order with a completion date of June 27, 2024. While the original solicitation was not provided, the...
This federal contract award is for the delivery of NALOXONE 0.4 MG/ML VIAL to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $2,449.46. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 14, 2025. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,566.20, is for the delivery of 4567152242 NALOXONE 4 MG/10 ML VIAL 10ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of February 5, 2025. The contract is not designated with a set-aside. Additionally, Amerisourcebergen holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of naloxone 0.4 mg/ml vials. The contract has a total ceiling value of $1,761.46 and is a firm fixed-price type contract. The period of performance extends through June 21, 2024. This award does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.4 mg/mL naloxone vials. The firm fixed-price contract has a ceiling value of $1,277.65 and a completion date of January 15, 2025. It is not designated as a set-aside contract. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the Defense Logistics Agency, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a $2,320.69 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,664,956 units of 4 mg naloxone hydrochloride nasal spray. This order is part of a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Naloxone 0.4 mg/mL vials. The contract has a ceiling value of $5,132.76 and a performance period through April 12, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,543.97, is for the delivery of 4567784822 naloxone 1mg/ml 10-count units. The contract has a firm fixed price pricing type and a period of performance running through April 30, 2025. This award appears to be part of a larger Indefinite Delivery Contract...
The federal contract award is for the delivery of 0.4 mg/mL vials of the medication naloxone, a critical drug used to treat opioid overdoses. The contract, valued at $2,132.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 11, 2025. The contract does not have a set-aside designation, indicating it was...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB24FWBE9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naloxone 0.4 mg/mL vials. The contract is a Delivery Order with a Firm Fixed Price of $1,842.80 and a completion date of July 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/21/24, 9:41 AM